1. Home
  2. WFCF vs KPTI Comparison

WFCF vs KPTI Comparison

Compare WFCF & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WFCF
  • KPTI
  • Stock Information
  • Founded
  • WFCF 1996
  • KPTI 2008
  • Country
  • WFCF United States
  • KPTI United States
  • Employees
  • WFCF N/A
  • KPTI N/A
  • Industry
  • WFCF Computer Software: Prepackaged Software
  • KPTI Biotechnology: Pharmaceutical Preparations
  • Sector
  • WFCF Technology
  • KPTI Health Care
  • Exchange
  • WFCF Nasdaq
  • KPTI Nasdaq
  • Market Cap
  • WFCF 53.4M
  • KPTI 44.5M
  • IPO Year
  • WFCF 2011
  • KPTI 2013
  • Fundamental
  • Price
  • WFCF $10.36
  • KPTI $4.42
  • Analyst Decision
  • WFCF
  • KPTI Buy
  • Analyst Count
  • WFCF 0
  • KPTI 6
  • Target Price
  • WFCF N/A
  • KPTI $48.50
  • AVG Volume (30 Days)
  • WFCF 1.9K
  • KPTI 71.5K
  • Earning Date
  • WFCF 08-07-2025
  • KPTI 08-05-2025
  • Dividend Yield
  • WFCF N/A
  • KPTI N/A
  • EPS Growth
  • WFCF N/A
  • KPTI N/A
  • EPS
  • WFCF 0.38
  • KPTI N/A
  • Revenue
  • WFCF $25,437,000.00
  • KPTI $142,126,000.00
  • Revenue This Year
  • WFCF N/A
  • KPTI $2.09
  • Revenue Next Year
  • WFCF N/A
  • KPTI $12.90
  • P/E Ratio
  • WFCF $27.57
  • KPTI N/A
  • Revenue Growth
  • WFCF N/A
  • KPTI 1.19
  • 52 Week Low
  • WFCF $9.26
  • KPTI $3.51
  • 52 Week High
  • WFCF $13.50
  • KPTI $17.40
  • Technical
  • Relative Strength Index (RSI)
  • WFCF 52.12
  • KPTI 44.98
  • Support Level
  • WFCF $10.00
  • KPTI $4.22
  • Resistance Level
  • WFCF $10.90
  • KPTI $4.62
  • Average True Range (ATR)
  • WFCF 0.17
  • KPTI 0.30
  • MACD
  • WFCF 0.08
  • KPTI 0.06
  • Stochastic Oscillator
  • WFCF 55.37
  • KPTI 56.41

About WFCF Where Food Comes From Inc.

Where Food Comes From Inc is a third-party food verification company. It offers food production audits and uses verification processes to ensure that claims made by food producers and processors are accurate. The company supports farmers, ranchers, vineyards, wineries, processors, retailers, distributors, trade associations, and restaurants with a wide variety of value-added services provided through its family of verifiers, including International Certification Services, Validus Verification Services, and others. The company operates in two segments that are verification and certification and Software Sales and Related Consulting. It generates the majority of its revenue from verification and certification.

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. The company derives its revenue from United States.

Share on Social Networks: